| Filed | Form | Description | |
|---|---|---|---|
| 5/2/25 | DEFA14A | DEFA14A | → |
| 3/27/25 | DEFA14A | DEFA14A | → |
| 3/27/25 | DEF 14A | DEF 14A | → |
| 4/22/24 | DEF 14A | DEF 14A | → |
| 4/6/23 | DEFA14A | DEFA14A | → |
| 4/6/23 | DEF 14A | DEF 14A | → |
| ↓ | |||
| Filed | Form | Description | |
|---|---|---|---|
| 2/26/26 | 4 | 4 | → |
| 2/26/26 | 3 | FORM 3 | → |
| 2/17/26 | 4 | 4 | → |
| 2/2/26 | 4 | 4 | → |
| 2/2/26 | 4 | 4 | → |
| 2/2/26 | 4 | 4 | → |
| ↓ | |||
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management.